{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:02:33Z","timestamp":1784005353071,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012304","name":"School of Medicine, Johns Hopkins University","doi-asserted-by":"publisher","award":["80062173"],"award-info":[{"award-number":["80062173"]}],"id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jtha.2025.07.016","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T23:09:59Z","timestamp":1753225799000},"page":"3640-3647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycoprotein VI is a receptor for the PF4\/anti-PF4 IgG complex and contributes to platelet activation in heparin-induced thrombocytopenia (HIT)"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5764-5454","authenticated-orcid":false,"given":"Ivo M.B.","family":"Francischetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Dane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed L.","family":"Galgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Streiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.07.016_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-Induced Thrombocytopenia: A Focus on Thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.07.016_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","author":"Greinacher","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.07.016_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ajh.24759","article-title":"Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia","volume":"92","author":"Kuter","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.07.016_bib4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.016_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.07.016_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12564","article-title":"A tail of two ITAMs: GPVI\/FcRgamma and FcgammaRIIa's role in platelet activation and thrombus stability","volume":"5","author":"Neeves","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.016_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imr.12370","article-title":"The platelet Fc receptor","volume":"268","author":"Qiao","year":"2015","journal-title":"FcgammaRIIa. Immunol Rev"},{"key":"10.1016\/j.jtha.2025.07.016_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood-2007-04-086983","article-title":"Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa","volume":"111","author":"Gardiner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.016_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V96.1.182","article-title":"Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation","volume":"96","author":"Newman","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.016_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-2143(96)90060-8","article-title":"Platelet binding of IgG from patients with heparin-induced thrombocytopenia","volume":"127","author":"Horne","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jtha.2025.07.016_bib11","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","article-title":"Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications","volume":"107","author":"Rauova","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.016_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2014-06-580894","article-title":"Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis","volume":"125","author":"Padmanabhan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.016_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood.2023020872","article-title":"PF4 activates the c-Mpl-Jak2 pathway in platelets","volume":"143","author":"Buka","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.016_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI122955","article-title":"Functional significance of the platelet immune receptors GPVI and CLEC-2","volume":"129","author":"Rayes","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.07.016_bib15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.jtha.2023.03.022","article-title":"Glycoprotein VI interplay with fibrin(ogen) in thrombosis","volume":"21","author":"Mangin","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.016_bib16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/09537104.2021.1945571","article-title":"Platelet activation by charged ligands and nanoparticles: platelet glycoprotein receptors as pattern recognition receptors","volume":"32","author":"Montague","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2025.07.016_bib17","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.07.016_bib18","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1182\/blood.2021013614","article-title":"Structural insights into collagen binding by platelet receptor glycoprotein VI","volume":"139","author":"Feitsma","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.016_bib19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.toxicon.2009.12.003","article-title":"Platelet aggregation inhibitors from hematophagous animals","volume":"56","author":"Francischetti","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.jtha.2025.07.016_bib20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/bloodadvances.2022007863","article-title":"Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition","volume":"7","author":"Billiald","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.07.016_bib21","doi-asserted-by":"crossref","first-page":"52293","DOI":"10.1074\/jbc.M406342200","article-title":"Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites","volume":"279","author":"Lecut","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.07.016_bib22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2012-01-407262","article-title":"Dynamic antibody-binding properties in the pathogenesis of HIT","volume":"120","author":"Sachais","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.016_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/ATVBAHA.111.241067","article-title":"Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity","volume":"32","author":"Loyau","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.07.016_bib24","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/j.1538-7836.2003.00495.x","article-title":"Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments","volume":"1","author":"Lecut","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.016_bib25","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1182\/bloodadvances.2020002861","article-title":"Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia","volume":"4","author":"Pishko","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.07.016_bib26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jth.12208","article-title":"FcgammaRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia","volume":"11","author":"Nazi","year":"2013","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:13:02Z","timestamp":1778818382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625004660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1538783625004660"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.07.016","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoprotein VI is a receptor for the PF4\/anti-PF4 IgG complex and contributes to platelet activation in heparin-induced thrombocytopenia (HIT)","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}